Effect of omega-3 fatty acid on oxidative stress in patients on hemodialysis

Iranian Journal of Kidney Diseases

Volumn 4, Issue 4, 2010, Pages 322-326

  Tayyebi Khosroshahi, Hamid ^a   Houshyar, Jalil ^a   Tabrizi, Ali ^a   Vatankhah, Amir Mansour ^b   Zonouz, Neda Razzagi ^a   Dehghan Hesari, Reza ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Glutathione peroxidase; Hemodialysis; Malondialdehyde; Omega 3 fatty acids; Oxidative stress; Superoxide dismutase

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; FERRITIN; GLUTATHIONE PEROXIDASE; HEMOGLOBIN; MALONALDEHYDE; OMEGA 3 FATTY ACID; PLACEBO; SUPEROXIDE DISMUTASE;

ADULT; AGE DISTRIBUTION; ALBUMIN BLOOD LEVEL; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG CAPSULE; DRUG EFFECT; DRUG MECHANISM; DRUG TOLERABILITY; ENZYME ACTIVITY; FATTY ACID OMEGA OXIDATION; FEMALE; FERRITIN BLOOD LEVEL; HEALTH STATUS; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAINTENANCE THERAPY; MALE; OXIDATION REDUCTION POTENTIAL; OXIDATION REDUCTION REACTION; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; SEX RATIO; TREATMENT DURATION;

DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; RENAL DIALYSIS; SUPEROXIDE DISMUTASE;

EID: 77957333569     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bloembergen WE, Port FK, Mauger EA, Wolfe RA. A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol. 1995;6:177-83.
2. London GM, Drueke TB. Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int. 1997;51:1678-95.
3. Baigent C, Burbury K, Wheeler D. Premature cardiovascular disease in chronic renal failure. Lancet. 2000;356:147-52.
4. Himmelfarb J. Linking oxidative stress and inflammation in kidney disease: which is the chicken and which is the egg? Semin Dial. 2004;17:449-54.
5. Kalousova M, Sulkova S, Fialova L, et al. Glycoxidation and inflammation in chronic haemodialysis patients. Nephrol Dial Transplant. 2003;18:2577-81.
6. Loughrey CM, Young IS, Lightbody JH, McMaster D, McNamee PT, Trimble ER. Oxidative stress in haemodialysis. Qjm. 1994;87:679-83.
7. Canaud B, Cristol J, Morena M, Leray-Moragues H, Bosc J, Vaussenat F. Imbalance of oxidants and antioxidants in haemodialysis patients. Blood Purif. 1999;17:99-106.
8. Ahmadpoor P, Eftekhar E, Nourooz-Zadeh J, Servat H, Makhdoomi K, Ghafari A. Glutathione, glutathione-related enzymes, and total antioxidant capacity in patients on maintenance dialysis. Iran J Kidney Dis. 2009;3:22-7.
9. Taccone-Gallucci M, Manca-di-Villahermosa S, Battistini L, Stuffler RG, Tedesco M, Maccarrone M. N-3 PUFAs reduce oxidative stress in ESRD patients on maintenance HD by inhibiting 5-lipoxygenase activity. Kidney Int. 2006;69:1450-4.
10. Katan MB. Fish and heart disease. N Engl J Med. 1995;332:1024-5.
11. [No author listed]. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-9.
12. Bucher HC, Griffith LE, Guyatt GH. Effect of HMGcoA reductase inhibitors on stroke. A meta-analysis of randomized, controlled trials. Ann Intern Med. 1998;128:89-95.
13. Panzetta O, Cominacini L, Garbin U, et al. Increased susceptibility of LDL to in vitro oxidation in patients on maintenance hemodialysis: effects of fish oil and vitamin E administration. Clin Nephrol. 1995;44:303-9.
14. Bonanome A, Biasia F, De Luca M, et al. n-3 fatty acids do not enhance LDL susceptibility to oxidation in hypertriacylglycerolemic hemodialyzed subjects. Am J Clin Nutr. 1996;63:261-6.
15. An SW, Kim HJ, Cho KH, Vaziri ND. Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney. Am J Physiol Renal Physiol. 2009;297:F895-903.
16. Cristol JP, Bosc JY, Badiou S, et al. Erythropoietin and oxidative stress in haemodialysis: beneficial effects of vitamin E supplementation. Nephrol Dial Transplant. 1997;12:2312-7.
17. Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant. 2003;18:1272-80.
18. Koenig JS, Fischer M, Bulant E, Tiran B, Elmadfa I, Druml W. Antioxidant status in patients on chronic hemodialysis therapy: impact of parenteral selenium supplementation. Wien Klin Wochenschr. 1997;109:13-9.
19. Nguyen-Khoa T, Massy ZA, De Bandt JP, et al. Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment. Nephrol Dial Transplant. 2001;16:335-40.
20. Gerardi G, Usberti M, Martini G, et al. Plasma total antioxidant capacity in hemodialyzed patients and its relationships to other biomarkers of oxidative stress and lipid peroxidation. Clin Chem Lab Med. 2002;40:104-10.
21. Allard JP, Kurian R, Aghdassi E, Muggli R, Royall D. Lipid peroxidation during n-3 fatty acid and vitamin E supplementation in humans. Lipids. 1997;32:535-41.
22. Fisher M, Levine PH, Weiner BH, et al. Dietary n-3 fatty acid supplementation reduces superoxide production and chemiluminescence in a monocyte-enriched preparation of leukocytes. Am J Clin Nutr. 1990;51:804-8.
23. Palleschi S, De Angelis S, Diana L, et al. Reliability of oxidative stress biomarkers in hemodialysis patients: a comparative study. Clin Chem Lab Med. 2007;45:1211-8.
24. Pastore A, Federici G, Bertini E, Piemonte F. Analysis of glutathione: implication in redox and detoxification. Clin Chim Acta. 2003;333:19-39.
25. Ceballos-Picot I, Witko-Sarsat V, Merad-Boudia M, et al. Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Radic Biol Med. 1996;21:845-53.
26. Iraz M, Erdogan H, Ozyurt B, Ozugurlu F, Ozgocmen S, Fadillioglu E. Brief communication: omega-3 essential fatty acid supplementation and erythrocyte oxidant/ antioxidant status in rats. Ann Clin Lab Sci. 2005;35:169-73.
27. Zararsiz I, Sonmez MF, Yilmaz HR, et al. Effects of omega-3 essential fatty acids against formaldehydeinduced nephropathy in rats. Toxicol Ind Health. 2006;22:223-9.
28. Romieu I, Garcia-Esteban R, Sunyer J, et al. The effect of supplementation with omega-3 polyunsaturated fatty acids on markers of oxidative stress in elderly exposed to PM(2.5). Environ Health Perspect. 2008;116:1237-42.
29. Kenar L, Karayilanoglu T, Aydin A, Serdar M, Kose S, Erbil MK. Protective effects of diets supplemented with omega-3 polyunsaturated fatty acids and calcium against colorectal tumor formation. Dig Dis Sci. 2008;53:2177-82.